Malignant Survivors

Eren Aydin · 2024 · $1.99 · Action · deal grade C

• Estimated net residual revenue: $29 to $44 per month
• Opportunity: $60 per month at x1.65 dormancy
• Estimated lifetime owners: 9.8k
• 63%% positive across 312 reviews · 2.5 reviews/month

Why it's flagged

• Developer silent for 20 months
• Studio quiet across its whole catalog
• Last build shipped 28 months ago

This case as Markdown · Estimates carry ±30-50%% error per title.